FDA.reportPublic FDA data

efmoroctocog alfa 1 UNT Injection [Eloctate]

RxCUI
1719611
RxNorm name
efmoroctocog alfa 1 UNT Injection [Eloctate]
Display name
efmoroctocog alfa 1 UNT Injection [Eloctate]
Full name
efmoroctocog alfa 1 UNT Injection [Eloctate]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125487EloctateAntihemophilic Factor (Recombinant), Fc Fusion protein351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e1419c33-ef07-4268-be1f-c8993502d597ELOCTATE 1 UNT Injection [PSN] · efmoroctocog alfa 1 UNT Injection [Eloctate] [SBD] · Eloctate 1 UNT Injection [SY]310These highlights do not include all the information needed to use ELOCTATE ® safely and effectively. See full prescribing information for ELOCTATE. ELOCTATE ® [Antihemophilic factor (recombinant), Fc fusion protein], Lyophilized powder for solution for intravenous injection Initial U.S. Approval: 201420230505